Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
*Correspondence: Shailendra Pratap Singh, [email protected] ORCID: sapna tiwari, orcid.org/0009-0000-5282-0324 Anjali Gupta, orcid.org/0009-0006-4759-9315 Deepa Pandey, orcid.org/0009-0005-0951-6761 Priyul Pandey, orcid.org/0009-0008-7084-2824 Rinkesh Gupta, orcid.org/0009-0006-9779-3618 Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Kidney and liver disease, in some cases
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
reported that L-carnitine supplementation in patients undergoing CABG significantly enhanced cardiac output, cardiac index, as well as left and right ventricular stroke work index both immediately following cardiopulmonary bypass and during the first postoperative hour (Furat et al
This fragment conserves the principal bioactive domain associated with T?4s regenerative activity
FDA has accepted a New Drug Application (NDA) for deucravacitinib, a potential "first-in-class" oral selective TYK2 inhibitor, for the treatment of adults with moderate/severe plaque psoriasis
US$ 20.27
US$ 26.16
US$ 23.99
US$ 27.58
US$ 20.29
US$ 21.82
US$ 22.62
US$ 21.43
US$ 23.56
US$ 26.14
